RIPK4 driven by TP53 mutations promotes resistance to redox stress of CRC by phosphorylating MTHFD1
Preprint in bioRxiv (August 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Lysophosphatidic acid down-regulates human RIPK4 mRNA in keratinocyte- derived cell lines
Article in PLOS ONE (April 2024)
miR-575/RIPK4 axis modulates cell cycle progression and proliferation by inactivating the Wnt/β-catenin signaling pathway through inhibiting RUNX1 in colon cancer
Article in Molecular and Cellular Biochemistry (March 2024)